PAUL J HASTINGS

CIK 1309702 · Chief Executive Officer · last filed 2026-01-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.41M

Companies

6

Total Filings

77

Lifetime Open-Market Net

-$3.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NKTX Chief Executive Officer 390,023 $2.86 $1.12M -$1.59M 21 2026-01-20
ENGNW Director $0.27 $0 2 2025-06-16
PCRX Director 12,724 $22.99 $292.5K -$2.27M 30 2024-06-13
PRTO Director $27.65 $0 3 2018-06-11
Relypsa Inc (RLYP) Delisted Director 0 -$69.9K 5 2016-09-02
VIACELL INC (VIAC) Delisted Director $29.58 $0 1 2007-06-01

Recent Filings · Page 6 of 8

77 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-06-17 PCRX Grant (A) +1,488 $0 EDGAR
2016-06-08 Relypsa Inc (RLYP) Delisted Sell (S) −1,013 -$19.6K EDGAR
2016-06-08 PCRX Sell (S) −1,136 -$53.3K EDGAR
2016-03-25 Grant (A) $0
2016-02-22 PCRX Mixed -$141.2K EDGAR
2016-01-08 Sell (S) −2,412 -$53.7K
2015-12-29 Grant (A) $0
2015-11-24 PCRX Mixed -$147.6K EDGAR
2015-08-19 PCRX Mixed -$147.6K EDGAR
2015-06-15 Relypsa Inc (RLYP) Delisted Sell (S) −1,454 -$50.4K EDGAR
Showing 5160 of 77
Page 6 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.